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Abstract
Background: Pragmatic randomised controlled trials (RCTs) are considered essential to determine effective
interventions for routine clinical practice, but many fail to recruit participants efficiently, and some really important
RCTs are not undertaken because recruitment is thought to be too difficult. The ‘QuinteT Recruitment Intervention’
(QRI) aims to facilitate informed decision making by patients about RCT participation and to increase recruitment.
This paper presents the development and implementation of the QRI.
Methods: The QRI developed iteratively as a complex intervention. It emerged from the National Institute for
Health Research (NIHR) ProtecT trial and has been developed further in 13 RCTs. The final version of the QRI uses a
combination of standard and innovative qualitative research methods with some simple quantification to
understand recruitment and identify sources of difficulties.
Results: The QRI has two major phases: understanding recruitment as it happens and then developing a plan of
action to address identified difficulties and optimise informed consent in collaboration with the RCT chief
investigator (CI) and the Clinical Trials Unit (CTU). The plan of action usually includes RCT-specific, as well as generic,
aspects. The QRI can be used in two ways: it can be integrated into the feasibility/pilot or main phase of an RCT to
prevent difficulties developing and optimise recruitment from the start, or it can be applied to an ongoing RCT
experiencing recruitment shortfalls, with a view to rapidly improving recruitment and informed consent or
gathering evidence to justify RCT closure.
Conclusions: The QRI provides a flexible way of understanding recruitment difficulties and producing a plan to
address them while ensuring engaged and well-informed decision making by patients. It can facilitate recruitment
to the most controversial and important RCTs. QRIs are likely to be of interest to the CIs and CTUs developing
proposals for ‘difficult’ RCTs or for RCTs with lower than expected recruitment and to the funding bodies wishing to
promote efficient recruitment in pragmatic RCTs.
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Background
Randomised controlled clinical trials (RCTs) are regarded
as the most effective and efficient study design for the
evaluation of healthcare interventions. Many RCTs have
identified successful interventions that have become wide-
spread or prevented the use of interventions thought to be
effective but shown to be harmful. Consultations have
shown high levels of willingness on the part of patients to
take part in research [1], and patient and public involve-
ment is now an integral part of RCT development in
many countries, including the US (http://www.pcori.org)
and UK (http://www.nihr.ac.uk/funding/pgfar-patient-
and-public-involvement.htm). The increasing complexity
and expense of contemporary clinical and public health
practice demands evidence from high-quality pragmatic
trials across the spectrum of health care. RCTs are be-
ing undertaken in increasing numbers to provide it. A
major problem with many RCTs, however, is difficulty
with participant recruitment [2]. Recruitment difficul-
ties can lead to RCTs requiring considerable additional
research resources in extensions, being underpowered
or failing to be completed, or taking so long that their
interventions become outdated. Reduced or restricted
recruitment may also have implications for the general-
isability of an RCT’s findings, particularly if only a very
small percentage of eligible patients are recruited over-
all or from particular centres in multi-centre trials or
particular groups of patients are not recruited such as
members of ethnic minorities or populations with the
greatest need.
Many attempts have been made to improve recruit-
ment, documented in systematic reviews [3–5], but
surprisingly few robustly evaluated or successful recruit-
ment strategies are generalizable [6].
Recruitment difficulties are poorly understood, mostly
because when they occur, chief investigators (CIs) and
Clinical Trials Units (CTUs) try to do everything they
can to improve recruitment, making it difficult to
work out what has made a difference [7]. Research
using qualitative methods has increased our under-
standing of recruitment, including that it is a complex
process rather than an event [8], is difficult for
patients because of its technical (non-lay) concepts
[9–11], and provokes ‘hidden’ challenges for recruiters
[12–14]. These accumulated understandings, allied
with the need for greater patient participation, have
enabled the development of an intervention that of-
fers opportunities to avoid or address recruitment dif-
ficulties, even in the most challenging trials. The
development of the intervention is reported here, in-
cluding details of its components and dual format
(for RCTs in development or underway with recruit-
ment problems), and a formative evaluation of its im-
plementation in several ongoing RCTs.
Methods
Intervention development
The development of the recruitment intervention
followed an iterative and accumulative process, and
while this largely mirrored guidelines now published
[15–17], it did not strictly follow all the recommenda-
tions, as they were not then available. The first version
of the recruitment intervention was developed in the
feasibility study of an RCT that was considered difficult
for recruitment: the NIHR ProtecT (Prostate cancer test-
ing and Treatment) trial with randomisation between
radical surgery, radical radiotherapy, and active monitor-
ing for clinically localised prostate cancer. This trial
started in 1999, and the recruitment was completed in
2009. The theoretical framework, the context for the
intervention, and the evolution and key components of
the framework have been published elsewhere [18–20].
Additional file 1 contains RCT registration details.
The initial version of the recruitment intervention was
then applied through the MRC Quartet (Qualitative
Research in Trials) programme in four RCTs expected
to have recruitment challenges in different contexts:
mental health, paediatrics, treatment for laryngeal can-
cer, and follow-up strategies following treatment for can-
cer [8]. Three RCTs completed recruitment successfully
(see, for example, [21]) and the other closed with clear
explication [22]. After further refinement, the near-final
intervention was applied to another cancer trial, which
also closed with clear reasons [23]. These six RCTs were
phase III, pragmatic, unblinded trials in feasibility stages
or full-scale recruitment, and all were considered chal-
lenging for recruitment because of very contrasting
arms, no-treatment comparators, or controversial clin-
ical contexts. The accumulated experience and data
from these RCTs were synthesised and used to finalise
the intervention, which was then applied in seven
further RCTs by the QuinteT (Qualitative Research Inte-
grated in Trials) team (http://www.bristol.ac.uk/social-
community-medicine/research/groups/social-sciences-health/
quintet/qri-rcts/). The intervention was named after the
team: the QuinteT Recruitment Intervention (QRI).
Research methods
The first version of the intervention applied in the
ProtecT trial had used primarily qualitative research
methods. The ProtecT feasibility study innovatively “em-
bedded the randomised trial within the qualitative study”
[18]. Qualitative, in-depth interviews were undertaken
with the patients eligible for randomisation as well as
the urologists and nurses who were undertaking recruit-
ment appointments and were analysed using standard
thematic approaches [24]. A crucial innovation was to
routinely audio-record all recruitment appointments.
Analysis of these interactions was instrumental in
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uncovering key issues that were hindering recruit-
ment—such as the recruiters’ difficulties in explaining
the ‘no-treatment’ arm and patients’ unwillingness to
accept it as ‘watchful waiting’ [18]. This finding led to
the detailed specification and re-naming of the option as
’active monitoring’, which better reflected its intention of
enabling patients to avoid unnecessary treatment under
close surveillance [18]. In time, further analysis of the re-
cruitment appointments revealed key aspects of commu-
nication that facilitated recruitment [25] and a nuanced
understanding that patient preferences, usually perceived
as a barrier to recruitment, could instead be explored to
facilitate enhanced informed consent and increased ran-
domisation [26, 27].
In the application of the intervention to the four fur-
ther RCTs in the Quartet Programme, however, it was
clear that standard methods of qualitative data collection
and analysis were too time-consuming when faced with
the demands of reporting findings and acting on them
to improve recruitment in ongoing RCTs [8]. Innovative
applications of existing methods, and new research
methods were thus developed. Targeted techniques of
analysis of audio-recordings of recruitment appoint-
ments were developed and implemented [18, 25],
adapted from conversation analysis [28], focusing, for
example, on interactions related to specific issues such
as randomisation. Simple quantification of eligible pa-
tients, patient pathways, and recruitment rates were added
to assess the complexity of the recruitment process. A
novel mixed-method approach, combining appointment
timings and qualitative interpretation—quanti-qualitative
appointment timing (Q-QAT)—was developed to identify
an unbalanced presentation of the RCT information hin-
dering recruitment [29]. Further developments to increase
the rapidity of data collection and analysis, while retaining
robustness, are underway.
The finalised intervention: the QRI
The final form of the QRI uses standard and innovative
qualitative research methods with simple quantification
to enable speedy implementation. In the sections that
follow, the findings from the development work that in-
formed the design of the QRI are presented with a clear
exposition of components of the QRI and examples of
its implementation in two RCTs. Ethical approval for the
research was obtained (see Additional file 1), and in-
formed consent to participate was obtained in writing.
Results
Findings from the development work
Valuable lessons were learned about applying the QRI in
the first six RCTs. Three RCTs had a feasibility phase
because the CI had anticipated recruitment difficulties;
three were undertaking main recruitment but suffered
severe recruitment problems. The RCTs included a
range of interventions, including drugs, surgery, radio-
therapy, and social support; sometimes the RCTs in-
cluded a ‘no-treatment’ comparator. Several issues arose
that made collaboration difficult. The need to put new
ethical processes and governance arrangements in place
for the QRI when RCTs were already underway caused
delays in commencing the research [8]. Although audio-
recording was included in the protocol, many recruiters
avoided or actively resisted taking recordings, and CIs
did not always appreciate its importance or support its
implementation. Recruitment pathways were often found
to be complicated, with variations between centres. The
time-consuming nature of the primarily qualitative re-
search, combined with delays in starting and a lack of
audio-recordings, made it difficult to implement the
intervention fully [8]. Most CIs acknowledged positive
contributions to recruitment from the intervention, includ-
ing having clear explanations for recruitment difficulties,
but it was often hard to define the precise contribution that
the intervention had made. It was concluded that QRIs
might best be integrated into feasibility studies and main
RCTs with committed CIs (like ProtecT) [8].
A gap in the literature in relation to the perspectives of
recruiters has been noted [6]. As in-depth interviews had
been conducted with RCT designers and recruiters in all
six RCTs as part of the development of the QRI, the find-
ings were re-analysed and synthesised to provide insights
into the perspectives of recruiters [12, 13]. In three of
these RCTs, doctors and nurses were undertaking recruit-
ment together, in two it was primarily nurses, and in one,
primarily doctors. The research synthesis revealed that the
recruitment process was complex and fragile, [12] with
‘clear obstacles’, defined as commonly reported organisa-
tional/logistical challenges, unexpectedly lower numbers
of eligible patients, strong patient preferences for particu-
lar interventions, and patients seemingly unwilling to con-
sider randomisation [3, 30]. In addition, the synthesis
identified a number of other previously undocumented is-
sues defined as ‘hidden challenges’, which were related to
recruiters’ difficulties with key aspects of the RCT design
and perceived conflicts between clinical and research roles
[12], and the emotional and intellectual challenges they
experienced when attempting to recruit patients [13].
The accumulated findings and experience from these
studies enabled the development of the finalised QRI,
described in full below.
The QuinteT Recruitment Intervention
The premise of the QuinteT Recruitment Intervention
(QRI) is simple, that is, to understand the reasons for re-
cruitment difficulties so that steps can be taken to ad-
dress them. This will ensure more efficient and effective
recruitment and engaged informed consent or clear
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documentation of why recruitment is not possible and
should cease. The aims of the QRI are thus as follows:
1. Understand the recruitment process in the RCT as
designed and implemented in its clinical setting,
including differences between centres in multi-
centre RCTs
2. Document reported recruitment barriers, and
understand the source of the difficulties—specifically
whether they are ‘clear obstacles’ or ‘hidden
challenges’ (see above and [12])
3. Assess the accuracy and clarity of the presentation
of the RCT by recruiters and the level of
engagement and informed consent achieved by
participants
4. Present evidence about generic and RCT-specific
recruitment difficulties to the CI, CTU, and Trial
Management Group (TMG) in a timely manner to
enable the production of a plan of improvement
5. To implement the plan of improvement as agreed
with the CI, CTU, and TMG
A QRI is undertaken in two main phases (see Fig. 1
for details):
QRI phase I: understanding recruitment
The aim of phase I is to understand how the RCT proto-
col is operationalised in clinical centres, to assess the
degree to which the RCT is integrated into the clinical ser-
vice, identify the patient pathway through eligibility as-
sessment and recruitment (including where potential
participants might be ‘lost’), assess levels of informed
consent, and elucidate ‘hidden challenges’ to recruitment
that are emerging unwittingly through the actions or
presentation of information by recruiters. There are four
mandatory (essential core activities) and one optional
(helpful but not essential) components, utilising standard
and innovative methods of data collection and analysis
undertaken by an experienced qualitative researcher:
1. In-depth interviews (mandatory)
In-depth semi-structured interviews are conducted
(and audio-recorded with consent) with the following:
– The CI and key members of the TMG involved in
the design and running of the RCT. These
provide an overview of their view of the design of
the RCT; the evidence underpinning it; details of
the intervention and control arms, terminology
used, and organisational arrangements; and views
about the reasons for recruitment difficulties.
– Individuals involved in presenting the RCT to
patients, including principal investigators
responsible for clinical centres, and clinical/
nurse/research staff who undertake the
assessment of the eligibility of participants or
have a role in explaining or presenting the details
Fig. 1 An outline of the QuinteT Recruitment Intervention (QRI) phases
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of the RCT. The most important are those who
formally obtain informed consent for
randomisation. A sample of staff may need to be
selected in large trials or centres (see below). The
aim is to understand the recruiters’ perspective of
the RCT design, evidence and protocol, and
recruitment pathways and challenges.
– Patients who have declined to take part in the
RCT. If recruitment is very low, patients can
provide interesting insights into how the RCT
has been presented by recruiters and why they
did not wish to take part.
Interviews should employ standard methods of
qualitative data collection, with attention to
sampling to ensure inclusion of a wide range of
views, for example using standard purposive
techniques to identify a range of experiences.
Interviews need to be audio-recorded and analysed
using constant comparison techniques with the aim of
drawing out key themes representing the perspectives
of those interviewed, including the identification of
‘clear obstacles’ and ‘hidden challenges’. Any data
presented must be anonymised.
2. Eligibility and recruitment logs, and charts of the
patient pathway (mandatory)
A flow chart should be completed in each clinical
centre to show the pathway that patients follow
from eligibility through randomisation, including
who they see, when they receive written information
about the RCT, who assesses eligibility, and who
describes the RCT to them in detail, including
gaining written informed consent and completing
the process of randomisation. A log of patients who
are potentially eligible should also be kept and
maintained by the RCT team. We have devised the
SEAR framework to assist with this – collecting
information on Screening (including those who
should be considered for the RCT according to the
protocol), Eligibility (including whether they met the
protocol inclusion/exclusion criteria, and for what
reason they were deemed ineligible), whether they
were Approached about RCT participation (if not -
why), and finally whether they were Randomised (if
not, why not and which treatment they received)
(Wilson C et al.: The Screening, eligibility, approached
and randomised framework for RCT recruitment,
forthcoming).
Simple counting of data collected in SEAR logs can
provide useful information about the complexity of
the recruitment process, and differences between
centres or over time can give indications of
difficulties that can be investigated further.
3. Audio-recording of recruitment appointments
(mandatory)
The most important part of the QRI is the analysis
of the interactions between recruiters and potential
RCT participants in the appointments where
recruiters explain the design and details of the RCT,
and patients decide whether or not to take part. The
routine audio-recording of such appointments can
provide extremely valuable information about
recruitment as it actually happens—information not
available directly from any other source. Time spent
explaining aspects of the RCT can be documented
and quantified using the Q-QAT technique, giving
useful indications of the order of presentation and
degree of balance between the RCT interventions,
and the time the RCT is first mentioned and how
long is devoted to it [29]. The audio-recordings of
the interaction between recruiter and participant
can be analysed using content, thematic and targeted
CA techniques to elucidate reasons for imbalances
in presentation, style and content of information
provided by the recruiter, participation and
engagement of patient, and indications of the
presence and origin of ‘hidden challenges’.
4. Study documentation (mandatory)
Patient information sheets (PIS), consent forms and
the study protocol should be scrutinised in the
context of findings from interviews and
appointments to identify aspects that might be
unclear or potentially open to misinterpretation.
5. Observations of investigator meetings (optional)
TMG meetings, site visits and other investigator
meetings may be observed and/or audio-recorded to
identify how the obstacles or challenges to recruitment
are being addressed.
QRI phase II: feedback to CI/TMG and plan of action
Phase II begins with the QRI researcher presenting sum-
maries of anonymised findings to the RCT CI and CTU
staff and to the TMG (if agreed earlier), including sup-
porting evidence. No identifiers of individuals or clinical
centres will be shown in presentations or reports de-
scribing the factors that appear to be hindering recruit-
ment. In some cases, the evidence from the QRI can
provide clear reasons why recruitment to the RCT may
not be achievable. In this situation, the QRI researcher
will prepare a report presenting the evidence for the CI/
TMG to facilitate their decision making. In most cases, a
potential plan of action to improve recruitment will be
proposed, based on the findings from the specific RCT
but also including experience from other QRIs for more
generic issues. Discussions will be held with the CI/
CTU/TMG to decide on the content of the plan (see
below) and responsibilities for implementation.
The plan of action is likely to include providing feed-
back and training to recruiters on issues such as how to
Donovan et al. Trials  (2016) 17:283 Page 5 of 11
present the RCT’s design and interventions more clearly
to improve levels of understanding and informed con-
sent, how to approach patients’ treatment preferences,
and, perhaps, facilitating discussions around ‘hidden’ is-
sues of eligibility assessment, equipoise, and team-
working, or potential changes to the protocol or patient
information and consent forms. The plan usually con-
tains a mix of generic RCT-related issues, such as ex-
planation of RCT procedures, and issues specific to the
particular RCT (such as the presentation of evidence); it
is the balance and combination of these that is the QRI’s
unique contribution. The plan may also recommend fur-
ther audio-recording of recruitment appointments or
documentation of the recruitment pathway, particularly
if either aspect has not been completed fully previously,
or inclusion of previously optional QRI elements (see
above). The implementation of the plan requires close
collaboration between the QRI team and the CI of the
RCT, and varies depending on the format of the QRI.
QRI implementation
The QRI is suitable for implementation in two formats:
1. Integrated into the feasibility/pilot or main phase of
RCTs for which recruitment is expected to be
difficult—aiming to prevent the development of
difficulties and optimise recruitment and informed
consent, addressing challenges as they arise
2. Applied to RCTs that are underway and showing
evidence of serious recruitment shortfalls that threaten
the continuation of the RCT–aiming to elucidate
opportunities for rapidly increasing recruitment or
clearly identifying insurmountable problems
The two phases of the QRI remain in both formats. As
the aims are subtly different, the intensity of the research
and speed of implementation of the plan will vary. When
applied to ongoing RCTs, if there is commitment to fa-
cilitate interviewing and audio-recording, phase I can be
implemented quickly, and its findings can be produced
within 2 months. When phase I is integrated into RCTs
in the pilot/feasibility/main stage, the speed of imple-
mentation of the QRI will depend on the rate of setting
up clinical centres. Implementing in feasibility/pilot
studies will often allow findings in an early recruiting
centre to be presented to others to encourage optimal
recruitment. Training sessions on generic issues can also
be provided. The QRI in the feasibility stage of the RCT
will also provide detailed data to support the establish-
ment of optimal recruitment practices for the main re-
cruitment stage. The materials developed by the QRI
team to provide generic support and training, modified
for each RCT in relation to the specific findings, can be
adapted as required by the different formats and stages.
Evaluating the impact of the QRI
The impact of the plan of action can be evaluated in the
following ways:
1. The recruitment log and pathway chart can be
repeated and compared with earlier versions.
2. Eligibility and randomisation rates can be assessed
before the plan of action is implemented and
regularly afterwards to check whether these rates
improve; it is helpful to look at these by clinical
centre and sometimes by individual recruiter.
3. Follow-up interviews can be undertaken with
recruiters to ask about the impact and acceptability
of the QRI and views about its effectiveness and the
changes that occur.
4. Interviews with patients can assess levels of
informed decision making.
5. Audio-recording of recruitment appointments post-
feedback can be used to investigate changes made
and their impact on decision making
The results of evaluations 1 and 2 will need to be inter-
preted cautiously as they will be observational before-and-
after findings, subject to a range of biases including the
introduction of the wide range of other things that CIs do
to improve recruitment [30]. For ongoing RCTs, the find-
ings are likely to be clearer as there will be a relatively
short phase I period and a summary of findings. In a feasi-
bility or pilot study, the findings from the integrated QRI
may be produced after relatively short periods in particu-
lar clinical centres, as the aim is to improve recruitment
over time, in an iterative manner.
The findings from the QRI can be reviewed with the CI/
CTU/TMG to decide how to address further needs. The
QRI team can provide evidence about the source of recruit-
ment difficulties and offer to provide feedback and facilitate
discussion, but it remains the decision of the CI and the
commitment of the TMG to enable such feedback and dis-
cussion to occur effectively. The CI, CTU, and TMG mem-
bers play an essential role in putting changes into practice
and encouraging others. Decisions can then be made about
the need for further feedback and training sessions, reviews
of particular clinical centres, presentations to groups of re-
cruiters, or provision of ‘tips for recruiter’ documents, or, if
changes are substantial, a re-launch of the RCT with an ad-
justed protocol and/or a re-drafted PIS. Such events can be
plotted on the recruitment chart (see [19] p. 31).
Examples of the implementation of each format of the
QRI in practice
To date, QRIs have been applied in 13 RCTs by the
QuinteT team (http://www.bristol.ac.uk/social-community-
medicine/research/groups/social-sciences-health/quintet/
qri-rcts/). An example of the implementation of each of
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the two formats is provided below to illustrate how the
QRI works in practice:
1. QRI in a feasibility study: the NIHR OPTIMA RCT
The QRI was established because recruitment was
anticipated to be difficult. The NIHR OPTIMA
‘Prelim’ feasibility and pilot study investigated
whether it was possible to recruit patients with
primary hormone-sensitive breast cancer, who were
at high risk of relapse by virtue of regional lymph
node metastases or tumour size, to a trial of
biomarker-directed treatment. Participants either
received chemotherapy followed by hormone
therapy treatment immediately (as per current
practice) or had treatment determined following a
test that had showed promise in indicating whether
tumours would be responsive to chemotherapy [31].
Patients randomised to receive the test would
receive standard treatment if the test indicated it
was needed or hormone therapy only if the test
indicated chemotherapy was not required. The CI
and TMG were concerned that patients would not
be willing to forego chemotherapy or be prepared to
wait for a test result, so a QRI was embedded in the
feasibility phase [31].
The QRI followed the phases and stages as indicated
above. Interviews with recruiting oncologists (n = 14)
revealed several ‘hidden challenges’ [31]. Although
recruiters expressed clear support and enthusiasm for
the RCT, at times, they also exhibited discomfort
about the eligibility criteria and hesitancy about
presenting the RCT to patients who, although they
were eligible for the RCT according to the protocol,
had clinical or other characteristics that they thought
should or should not require chemotherapy. Analysis
of audio-recorded appointments (n = 36) revealed that
recruiters mostly provided clear and detailed diagnostic
information but sometimes found it difficult to suspend
routine practices that contradicted the RCT’s premise,
for example, unwittingly recommending chemotherapy.
Some recruiters also found it difficult to explain the
RCT design and treatment allocation in lay terms,
particularly as in the OPTIMA RCT, the ‘test-directed’
treatment arm was divided into two distinct allocations,
depending on the result of the test. Review of the
first study PIS identified several occasions where
explanations of the treatment allocation had the
potential to lead to confusion.
The QRI plan of action agreed on by the CI and
TMG for the OPTIMA RCT involved drafting and
dissemination of ‘tips and guidance’ sheets to
recruiters, amendments to the PIS, and a series of
individual and group feedback sessions. Tips and
guidance sheets provided recommendations on how
to introduce the study and explain the trial design,
with similar approaches taken to clarify the
information provided in the PIS. More subtle
difficulties such as issues of equipoise around
eligibility criteria and problematic terminology were
discussed in four regional group feedback sessions
attended by oncologists, research nurses, members
of the TMG, and the CI. Clinical vignettes displaying
patients at the extremes of eligibility criteria were
displayed and discussed to air discrepancies in
opinion and sources of discomfort. More delicate
issues of managing ‘gut instincts’ when approaching
patients were discussed through confidential
individual feedback sessions with recruiting
oncologists (n = 4).
Full details of the QRI integrated in the feasibility
‘prelim’ study and how the recruitment targets were
reached have now been published [31]. The NIHR
OPTIMA RCT has now been funded for full-scale
recruitment, with a further integrated QRI to
optimise recruitment. Findings from the QRI are
being used to inform training and further drafts of
guidance for recruiters to be implemented in the
large number of new centres in the full-scale RCT.
2. QRI in an ongoing RCT with recruitment
difficulties: the ARUK CSAW trial
The CSAW RCT aimed to investigate the
effectiveness of treatment for subacromial pain in
the shoulder by comparing active surgery
(arthroscopic subacromial decompression), an
investigational shoulder arthroscopy without
surgery, and a non-operative option with monitoring
and specialist assessment [32]. The research included
an opportunity for patients who did not want to
join the RCT to participate in a ‘preference’ study
(observational follow-up of patients indicating a
preference for a particular treatment). The QRI was
established after recruitment had been undertaken for
8 months but was falling behind the target figure,
leading the funder ARUK (Arthritis Research UK) to
issue an alert expressing concern.
The applied QRI broadly followed the phases and
stages as indicated above. Interviews were held with
four members of the TMG and 13 recruiters from
six clinical centres. Logs documenting eligibility and
recruitment were monitored on an ongoing basis,
and patient pathways were tracked from each of the
six centres. Recruitment appointments (n = 25) were
recorded in four centres. The recruitment difficulties
included both clear obstacles and hidden challenges.
The most important issue was a lack of equipoise
among recruiters. This led to hesitant presentation
of the RCT to patients, particularly those who,
although eligible for the RCT, were thought to ‘need’
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surgery. A lack of consistency and balance existed in
how the treatment arms were described, with
difficulties particularly in relation to explaining the
monitoring option. The existence of the ‘preference’
study meant that recruiters could readily accept
patient preferences without exploration, and this
acted to discourage participation in the RCT.
The findings from the QRI were fed back to the CIs
and members of the core CSAW RCT team after
4 months. The presentation of the anonymised
findings provoked a detailed discussion about the
equipoise issues, options for the clearer presentation
of the RCT, and the QRI team’s suggestion to close
the preference study. This was the first part of the
plan of action, which also included personalised
feedback, the inclusion of recruitment ‘tips’ in the
RCT newsletter, and a training day attended by
more than 40 recruiters from 15 centres during
which the QRI findings were presented and
proposed improvements discussed. In addition, there
were five ‘trouble-shooting’ visits to centres that had
found recruitment particularly difficult, and a
guidance document on how to structure recruitment
appointments was sent to all participating centres;
this document was based on the QRI findings and
the discussions from the training day. The RCT
completed recruitment after 35 months, and the
findings are awaited [32].
Discussion
A recruitment intervention (the QRI) has been devel-
oped to address recruitment challenges, and has been
applied successfully in 13 RCTs to date. ‘Success’ is
achieved either by optimising practices that enable re-
cruitment to be completed in feasibility/pilot or main
RCTs, or providing detailed evidence to support a deci-
sion to cease recruitment. A major aim of a QRI is to
understand the recruitment process as it happens and to
address clear obstacles and hidden challenges [12] to the
provision of clear and accurate information to facilitate
informed decision-making by patients about RCT par-
ticipation. The QRI uses standard and innovative re-
search methods (primarily qualitative and some simple
quantification) to provide a clear understanding of the
application of the RCT protocol in clinical settings. The
first phase of the QRI investigates eligibility assessment
and recruitment from the perspective of RCT designers
and recruiters in interviews as well as the recruitment
process as it actually happens through data collected in
logs, and also how the RCT is presented to potential
participants in study documents and audio-recordings of
appointments. In phase II, anonymised feedback of the
phase I QRI findings to the CI/CTU/TMG enables the
development of a specifically tailored ‘plan of action’ to
improve recruitment and informed consent. A key part
of the plan is anonymised feedback, based on the find-
ings, to groups of recruiters, to particular clinical cen-
tres, or confidentially to individual recruiters. This
feedback encourages reflection about the emotional and
intellectual challenges that recruiters (doctors or nurses)
often experience, particularly in relation to equipoise,
patient eligibility, and perceived role-conflict [13]. An-
other important aspect of the plan of action is to ensure
that information about the RCT is presented as clearly
and understandably as possible to increase patient un-
derstanding of the rationale of the RCT and the practi-
calities of research participation. The main aim is to
encourage greater patient and recruiter engagement in
decision making—with evidence from audio-recordings
of participation in appointments—as well as written in-
formed consent [25]. A description of the Phases that
constitute the QRI and two examples of its application
in two different RCT contexts provide guides to its use
more widely.
Recruitment is frequently identified as a major prob-
lem for RCTs [2, 4]. Interventions that lead to more ef-
fective and efficient recruitment are urgently required,
particularly as so many systematic reviews have identi-
fied so few [6, 33]. The small number of effective inter-
ventions that have been identified have tended to focus
on simple administrative aspects aimed at RCT partici-
pants, such as ways to increase questionnaire responses
[6]. Few have supported recruiters, although there is evi-
dence of demand for these [5, 14]. Most interventions
have been developed to address issues identified within
particular RCTs, as CIs and RCT staff attempt to do
everything they can to rectify poor recruitment. This
limits the generalisability of interventions and deals only
with issues that are clearly evident to CIs and RCT staff
(not the ‘hidden’ challenges [13]).
The QRI was developed to address the limitations with
existing interventions in three ways. First, it was devel-
oped to understand the recruitment process as it oc-
curred in clinical centres and from the perspectives of
recruiters and patients—through the use primarily of
qualitative research methods. Second, during its devel-
opment period, it was applied in as many different sorts
of RCTs as possible. Third, it sought to address the diffi-
culties that arose for recruiters and potential participants
by actively optimising recruitment quality and informed
consent.
In terms of its development using qualitative methods,
the QRI built on pioneering research that was conducted
alongside pragmatic RCTs (or integrated within them) and
produced important incremental insights about under-
standing experiences of RCT participation. Several groups
illuminated, for example, the difficulties for patients aris-
ing from poor explanations of randomisation [9, 10] and
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the importance of clear presentation of equipoise
[34, 35]. A small number of studies explored the experi-
ences of clinician recruiters [14, 36, 37]. More recently, a
synthesis of interviews conducted with recruiters during
the application of the developmental version of the QRI in
six RCTs led to a detailed and nuanced understanding of
recruitment as a complex and fragile process, fraught with
logistical/organisational obstacles, and the identification of
several previously hidden emotional and intellectual
challenges for recruiters [12, 13].
The application of the QRI in a wide range of different
RCTs in terms of their designs, clinical contexts, and re-
cruitment processes provided opportunities to identify
generic as well as RCT-specific outcomes. While there
were specific recruitment issues in most of the RCTs that
were of interest to specialists, [21–23], there were also
findings of more generic concern that fed into the further
development of the QRI [8]. The final version of the QRI
emerged from the symbiotic relationship between the in-
sights gained from the qualitative research about recruit-
ment from the perspectives of patient participants and
clinician/nurse recruiters and the implementation of the
plan by recruiters to improve recruitment based on those
understandings. The theoretical background justifying this
approach originates from the view that RCTs are Complex
Adaptive Systems (CAS)—collections of individual agents
(recruiters) with the freedom to act in ways that are not
always predictable [38]. There is a need with CAS to
understand the contextual factors influencing behaviour
(QRI-determined clear obstacles and hidden challenges),
with built-in feedback loops to enable changes to agents’
actions (the QRI plan of action).
The necessity of integrating the QRI in the RCT re-
flects its holistic approach to optimising recruitment and
the need to engage patients and recruiters in the
process. Its aim is to ensure that the presentation of the
RCT is accurate and fair, so that recruiters and patients
can fully discuss the purpose of the research, and pa-
tients can make informed decisions about whether to
take part. The neglected aspect in many previous inter-
ventions has been the lack of understanding about re-
cruiters’ views and instincts about the RCT. Clinicians
need to be ‘in equipoise’ to believe that there is no ad-
vantage or disadvantage for a patient to receive one of
the RCTs arms [39] and to be uncertain about the best
option because of the lack of evidence [40]. There have
been many debates about the philosophical issues
underlying equipoise, but now it has also been shown
empirically that it raises immense difficulties for some
recruiters, and that they may need support and training
to deal with it [13, 14, 36]. Further, if these ‘hidden’ is-
sues are not openly discussed, the presentation of the
RCT to patients is likely to be affected and the participa-
tion and decision making of the patients may be
compromised [12]. The feedback process in the QRI en-
courages recruiters to reflect on factors such as their
own understanding of the evidence, their own equipoise,
the balance between community equipoise with col-
leagues and in relation to actual patients, and the poten-
tial conflicts that can emerge from combined clinical
and research roles [12].
For patients (potential RCT participants), the provision
of clear information is crucial for fully informed consent.
Ethics and governance procedures should ensure this, but
they focus primarily on the written PIS. Audio-recording
recruitment appointments in the QRI has shown that
these interactions are crucial for enabling patient engage-
ment with difficult aspects of RCT participation such as
preferences [27]. Ultimately, full engagement of patients
as potential participants will be beneficial for recruitment
to RCTs. When clinicians and other recruiters, as well as
patients, perceive that participating in the RCT is an ap-
propriate decision in the face of uncertainty regarding the
optimal treatment, a more engaged and participatory form
of informed consent can be achieved. This is the primary
aim of the QRI, and if there is no confidence in the RCT,
recruitment should not continue (see, for example, [22]).
The costs of a QRI primarily relate to the need to em-
ploy an experienced qualitative researcher at 0.5 FTE for
the first year of recruitment (with associated on-costs
and overheads, this amounts to c.£60–80,000). A formal
cost-effectiveness analysis has not yet been undertaken,
but if the QRI is effective in increasing recruitment, the
costs of the main RCT are likely to be reduced.
Strengths and limitations of the QRI
The strength of the QRI is its grounding in a nuanced
understanding of the recruitment process based on its
own and others’ qualitative research, its focus on the
needs of recruiters and potential participants, and its ap-
plication in RCTs that anticipate recruitment challenges,
or are underway and experiencing difficulties. It is lim-
ited, however, by the availability of only observational
evidence of its effectiveness and not yet proven cost-
effectiveness. Undertaking a randomised study to ro-
bustly evaluate it is a goal, but this is not without severe
difficulties. An RCT of QRIs applied to feasibility or
pilot RCTs would be particularly difficult, as the iterative
nature of the data collection and spread of the influence
of feedback and training across centres produces an ac-
cumulation of evidence rather than enabling analysis of
a static primary outcome. QRIs applied to ongoing RCTs
with recruitment shortfalls might be possible as
there is then a more rapid data collection period
and a clearer implementation phase. But there are
then questions about whether to randomise clinical
centres or whole RCTs, which would present practical and
methodological challenges unless a sizable funding body
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agreed to randomise its portfolio of RCTs with recruit-
ment problems. There would remain, however, the thorny
issue of what the outcome measure would be. Simple
quantitative measures of eligibility and recruitment rates
could be used, but they are only part of the story. Of
greater importance is the quality of the recruitment as
represented by evidence of truly engaged and informed
consent by participants. Such a measure is currently under
development in QuinteT as existing measures focus pri-
marily on recruiter information provision [41, 42].
Other aspects that remain to be evaluated include levels
of compliance with the randomised allocation and
whether the QRI leads to greater or lesser longer-term re-
tention. Another potential limitation is that QRIs have
only been implemented by one team—QuinteT (http://
www.bristol.ac.uk/social-community-medicine/research/
groups/social-sciences-health/quintet/qri-rcts/)—although
several CIs, CTUs and TMGs have been involved. This
paper is aimed at enabling others to understand the basis
and methods, so the intervention can be spread in collab-
oration with the QuinteT team and/or implemented more
widely. It is important to note that many of the qualitative
methods underlying the QRI are standard: in-depth inter-
views, content, and thematic approaches to analysis using
the techniques of constant comparison, for example. The
QuinteT team has also developed several innovative
methods to address particular issues, such as Q-QAT to
assess the balance of information provision [23]. Other as-
pects, however, will be unfamiliar to traditional qualitative
researchers, including the use of targeted methods of data
collection and analysis that are essential to produce find-
ings quickly while retaining robustness. Another unfamili-
arity is the intention of the QRI at the outset to influence
the conduct of the recruitment process of the RCT and
put into place opportunities for discussion and feedback
that may lead to changes to RCT recruitment, overall con-
duct, or even design. The QuinteT team has developed
working methods and team approaches to support the re-
search; it will be interesting to see how much of this is
transferable.
Conclusion
The QRI provides a flexible way of understanding re-
cruitment difficulties and producing a plan of action to
address them and ensure engaged and well-informed de-
cision making by patients. A QRI integrated into an
RCT at the feasibility/pilot/main trial stage can be used
to elicit recruitment challenges with a view to preventing
them or addressing them as they arise. Used in this way,
the QRI can ensure that recruitment to even the most
difficult and controversial (but important) RCTs can be
attempted. Where recruitment difficulties have devel-
oped unexpectedly, the QRI can be applied to the RCT
to identify the sources of the difficulties and provide
evidence to improve recruitment or discontinue it. QRIs
are likely to be of interest to CIs and CTUs developing
proposals for ‘difficult’ RCTs and for those RCTs with
lower than expected recruitment. In addition, while it
has not been formally studied, QRIs should lead to more
efficient completion of RCTs with enhanced patient par-
ticipation, which should be of interest to funding bodies.
Additional file
Additional file 1: Contains details of ethical approvals for the RCTs and
ProtecT trial registrations. (DOCX 45 kb)
Abbreviations
CI, chief investigator; Q-QAT, quanti-qualitative appointment timing; QRI,
Quintet Recruitment Intervention; RCT, randomised controlled trial
Acknowledgements
Funding for the development of the QRI came from the National Institute
for Health Research (NIHR) ProtecT study (90/20/06 and 90/20/99) and
Medical Research Council (Quartet and ConDuCT (Collaboration and
innovation for Difficult and Complex randomised controlled Trials In Invasive
procedures – MR/K025643/1) Hub for Trials Methodology Research). The
funding bodies had no role in the design or conduct of the study; the
collection, management, analysis, and interpretation of the data; or the
preparation, review, or approval of the article. JLD was supported by the
NIHR Collaboration for Leadership in Applied Health Research and Care
(CLAHRC) West at University Hospitals Bristol NHS Foundation Trust and by
an NIHR Senior Investigator award to develop the Quintet team approach,
which was also supported by the MRC ConDuCT-II Hub. JMB also has an
NIHR Senior Investigator award. This article presents independent research
funded by NIHR and the MRC. The views expressed are those of the authors
and not necessarily those of the MRC, NHS, NIHR, or the Department of Health.
We would particularly like to acknowledge the contributions of the RCT
investigators, CTUs, and recruiters who participated in QRIs, and especially
Rob Stein and David Beard for permission to use summaries of the QRIs in
their RCTs as examples in this paper. Particular thanks go to them and the
following for important contributions to the QRIs during the development
phase: Freddie Hamdy, Alison Birtle, Alison Halliday, Damian Griffin, Andrew
Carr, Martin Birchall, Louise Howard, and Chris Rogers. The QuinteT team also
acknowledges the contributions of Rebecca Barnes, Isabel de Salis, Merran
Toerien, Zelda Tomlin, Carmel Conefrey, and Paul Whybrow.
Authors’ contributions
JLD conceived the idea for the recruitment intervention, undertook the
research for the developmental version of the QRI, and led the QuinteT
research programme that developed the QRI. SP, LR, MJ, DT, JW, KA, NM, and
CW collected, analysed, and interpreted the data within the QRIs and
contributed to the development of the final format of the QRI. JMB
contributed to the development of the QRI through her involvement in its
implementation and modification. JLD drafted the manuscript, and all other
authors read, commented on, and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 24 October 2015 Accepted: 6 May 2016
References
1. Medical Research Council. The use of personal health information in
medical research. general public consultation. 2007. http://www.mrc.ac.uk/
about/how-the-public-can-get-involved/public-consultations/public-
consultation-on-the-use-of-personal-health-information-in-research-
ongoing/. Accessed 24 May 2016.
Donovan et al. Trials  (2016) 17:283 Page 10 of 11
2. McDonald AM, Knight RC, Campbell MK, Entwistle VA, Grant AM, Cook JA,
et al. What influences recruitment to randomised controlled trials? Trials.
2006;7:9.
3. Mc Daid C, Hodges Z, Fayter D, Stirk L, Eastwood A. Increasing participation
of cancer patients in randomised controlled trials: a systematic review. Trials.
2006;7:16. doi:10.1186/1745-6215-7-16.
4. Fletcher B, Gheorghe A, Moore D, Wilson S, Damery S. Improving the
recruitment activity of clinicians in randomised controlled trials: a systematic
review. BMJ Open. 2012;2:496. doi:10.1136/bmjopen-2011-000496.
5. Bower B, Brueton V, Gamble C, Treweek S, Tudur Smith C, Young B, et al.
Interventions to improve recruitment and retention in clinical trials: a survey
and workshop to assess current practice and future priorities. Trials. 2014;15:
399. doi:10.1186/1745-6215-15-399.
6. Treweek S, Lockhart P, Pitkethly M, Cook J, Kjeldstrøm M, Johansen M,
Taskila T, Sullivan F, Wilson S, Jackson C, Jones R, Mitchell E. Methods to improve
recruitment to randomised controlled trials: Cochrane systematic review and
meta-analysis. BMJ Open. 2013;3. doi:10.1136/bmjopen-2012-002360.
7. Longbottom ME, Roberts JN, Tom M, Hughes SE, Howard VJ, Sheffet AJ, et
al. Interventions to increase enrolment in a large multicenter phase 3
trial of carotid stenting vs. endarterectomy. Int J Stroke. 2012;7:447–543.
doi:10.1111/j.1747-4949.2012.00833.
8. De Salis I, Tomlin Z, Toerien M, Donovan J. Qualitative research to improve
RCT recruitment: issues arising in establishing research collaborations.
Contemp Clin Trials. 2008;29:663–70.
9. Snowdon C, Garcia J, Elbourne D. Making sense of randomization:
responses of parents of critically ill babies to random allocation of
treatment in a clinical trial. Soc Sci Med. 1997;45(9):1337–55.
10. Featherstone K, Donovan JL. Random allocation or allocation at random?
Patient perspectives of participation in a randomised controlled trial. BMJ.
1998;317:1177–80.
11. Behrendt C, Golz T, Roesler C, Bertz H, Wünsch. What do our patients
understand about their trial participation? Assessing patients’ understanding
of their informed consent consultation about randomized clinical trials.
J Med Ethics. 2011;37:74–80. doi:10.1136/jme.2010.035485.
12. Donovan JL, Paramasivan S, de Salis I, Toerien M. Clear obstacles and
hidden challenges: understanding recruiter perspectives in six pragmatic
randomised controlled trials. Trials. 2014;15(5):1–12. doi:10.1186/1745-6215-15-5.
13. Donovan JL, de Salis I, Toerien M, Paramasivan S, Hamdy FC, Blazeby JM.
The intellectual challenges and emotional consequences of equipoise
contributed to the fragility of recruitment in six randomised controlled
trials. J Clin Epidemiol. 2014;67(8):912–20.
14. Lawton J, Kirkham J, White D, Rankin D, Cooper C, Heller S. Uncovering the
emotional aspects of working on a clinical trial: a qualitative study of the
experiences and views of staff involved in a type 1 diabetes trial. Trials. 2015;16:3.
15. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I. Developing and
evaluating complex interventions: the new Medical Research Council
guidance. BMJ. 2008;337:a1655.
16. Mohler R, Kopke S, Meyer G. Criteria for reporting the development and
evaluation of complex interventions in healthcare: revised guideline
(CReDECI 2). Trials. 2015;16:204.
17. Hoffman TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better
reporting of interventions: template for intervention description and
replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.
18. Donovan JL, Mills N, Smith M, Brindle L, Jacoby A, Peters TJ, et al. Improving
design and conduct of randomised trials by embedding them in qualitative
research: ProtecT (prostate testing for cancer and treatment) study. BMJ.
2002;325:766–70.
19. Donovan JL, Lane JA, Peters TJ, Brindle L, Salter E, Gillatt D, et al.
Development of a complex intervention improved randomization and
informed consent in a randomised controlled trial. J Clin Epidemiol.
2009;62:29–36.
20. Lane JA, Donovan JL, Davis M, Walsh E, Dedman D, Down L, et al. Active
monitoring, radical prostatectomy, or radiotherapy for localised prostate
cancer: study design and diagnostic and baseline results of the ProtecT
randomised phase 3 trial. Lancet Oncol. 2014;15(10):1109–18.
21. Howard L, de Salis I, Tomlin Z, Thornicroft G, Donovan JL. Why is
recruitment to trials difficult? An investigation into recruitment difficulties in
an RCT of supported employment for people with severe mental illness.
Contemp Clin Trials. 2009;30:40–6.
22. Hamilton DW, de Salis I, Donovan JL, Birchall M. The recruitment of patients
to trials in head and neck cancer: a qualitative study of the EaStER trial of
treatments for early laryngeal cancer. Eur Arch Oto-Rhino-Laryngol Head
Neck. 2013. doi: 10.1007/s00405-013-2349-8.
23. Paramasivan S, Huddart R, Hall E, Lewis R, Birtle A, Donovan JL. Key issues in
recruitment to randomised controlled trials with very different interventions:
a qualitative investigation of recruitment to the SPARE trial. Trials. 2011;12:78.
24. Hammersley P, Atkinson M. Ethnography: principles and practice. London:
Routledge; 1983.
25. Wade J, Donovan JL, Lane JA, Neal DE, Hamdy FC. It’s not just what you say,
it’s also how you say it: opening the ‘black box’ of informed consent
appointments in randomised controlled trials. Soc Sci Med. 2009;68:2018–28.
26. Mills N, Donovan JL, Wade J, Hamdy FC, Neal DE, Lane JA. Exploring
treatment preferences facilitated recruitment to randomised controlled
trials. J Clin Epidemiol. 2011;64:1127–36.
27. Mills N, Blazeby JM, Hamdy FC, Neal DE, Campbell B, Wilson C, et al.
Training trial recruiters to randomised trials to facilitate recruitment and
informed consent by exploring patients’ treatment preferences. Trials.
2014;15:323. doi:10.1186/1745-6215-15-323.
28. Sidnell J, Stivers T, editors. The handbook of conversation analysis. Oxford:
Wiley-Blackwell; 2015.
29. Paramasivan S, Strong S, Wilson CH, Campbell B, Blazeby JM, Donovan JL.
A simple technique to identify key recruitment issues in randomised
controlled trials: Q-QAT – quanti-qualitative appointment timing. Trials.
2015;16:88.
30. Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R,
Entwistle V, Garcia J, Roberts I, Grant A. STEPS review 2007. Health Technol
Assess. 2007;11(48):1-105.
31. Stein RC, Dunn JA, Bartlett JMS, Campbell AF, Marshall A, et al. OPTIMA: The
clinical and cost effectiveness of personalised care in the treatment of
women with breast cancer – preliminary study. Health Technol Assess. 2016;
20(10):1–202. doi:10.3310/hta20100.
32. Beard D, Rees J, Rombach I, Cooper C, Cook J, Merritt N, et al. The CSAW
Study (Can Shoulder Arthroscopy Work?) – a placebo-controlled surgical
intervention trial assessing the clinical and cost effectiveness of arthroscopic
subacromial decompression for shoulder pain: study protocol for a
randomised controlled trial. Trials. 2015;16:210.
33. Caldwell PHY, Hamilton S, Tan A, Craig JC. Strategies for Increasing
Recruitment to Randomised Controlled Trials: Systematic Review. PLoS Med.
2010;7(11):e1000368. doi:10.1371/journal.pmed.1000368.
34. Garcia J, Elbourne D, Snowdon C. Equipoise: a case study of the views of
clinicians involved in two neonatal trials. Clin Trials April. 2004;1(2):170–8.
35. Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC. Perceptions of
equipoise are crucial to trial participation: a qualitative study of men in the
ProtecT study. Control Clin Trials. 2003;24:272–82.
36. Taylor KM. Integrating conflicting professional roles: physician participation
in randomized controlled trials. Social Sci Med. 1992;35(2):217e24.
37. Ziebland S, Featherstone K, Snowdon C, Barker K, Frost H, Fairbank J. Does it
matter if clinicians don’t understand what the trial is really about?
Qualitative study of surgeons’ experiences of participation in a pragmatic
multi-centre RCT. Trials. 2007;8:4.
38. Plsek PE, Greenhalgh T. Complexity science: the challenge of complexity in
health care. BMJ. 2001;323:625–8.
39. Fried C. Medical experimentation: personal integrity and social policy.
Amsterdam: North-Holland Publishing; 1974.
40. Weijer C, Shapiro SH, Cranley GK. For and against: clinical equipoise and not
the uncertainty principle is the moral underpinning of the randomized
controlled trial. Br Med J. 2000;321(7263):756–8.
41. Brown RF, Butow PN, Butt DG, Moore AR, Tattersall MHN. Developing ethical
strategies to assist oncologists in seeking informed consent to cancer
clinical trials. Soc Sci Med. 2004a;58:379–90.
42. Albrecht TL, Eggly SS, Gleason MEJ, Harper FWK, Foster TS, Peterson AM, et
al. Influence of clinical communication on patients’ decision making on
participation in clinical trials. J Clin Oncol. 2008;26:2666–73.
Donovan et al. Trials  (2016) 17:283 Page 11 of 11
